D. L. Scott, F. Wolfe, and T. W. Huizinga, Rheumatoid arthritis. The Lancet, vol.376, pp.1094-108, 2010.

L. Carmona, M. Cross, B. Williams, and M. Lassere, Lyn March Q. Rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 2010.

A. Syed, M. Fazal, S. E. Khan, F. Nishi, N. Alam et al., Ashraf. A Clinical Update and Global Economic Burden of Rheumatoid Arthritis

. Researchgate,

K. Hameed and T. Gibson, A comparison of the prevalence of rheumatoid arthritis and other rheumatic diseases amongst Pakistanis living in England and Pakistan, Br J Rheumatol. juill, vol.36, issue.7, pp.781-786, 1997.

A. J. Svendsen, K. O. Kyvik, G. Houen, P. Junker, K. Christensen et al., On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes-A Population Based Twin Study

S. K. Ahuja, PLoS ONE, vol.8, issue.2, p.57304, 2013.

C. M. Weyand, K. C. Hicok, D. L. Conn, and J. J. Goronzy, The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis, Ann Intern Med, vol.117, issue.10, pp.801-807, 1992.

T. L. Lenz, A. J. Deutsch, B. Han, X. Hu, Y. Okada et al., Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases, Nat Genet, vol.47, issue.9, pp.1085-90, 2015.

D. Yu, C. Qu, O. Henegariu, X. Lu, and G. Feng, Protein-tyrosine Phosphatase Shp-2 Regulates Cell Spreading, Migration, and Focal Adhesion, J Biol Chem, vol.273, issue.33, pp.21125-21156, 1998.

B. Marston, A. Palanichamy, and J. Anolik, B cells in the pathogenesis and treatment of rheumatoid arthritis, Current Opinion in Rheumatology. 1 mai, vol.22, issue.3, pp.307-322, 2010.

L. Yeo, K. Toellner, M. Salmon, A. Filer, C. D. Buckley et al., Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis, Ann Rheum Dis. 8 juill, vol.70, issue.11, pp.2022-2030, 2011.

, B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers

D. Sur,

B. R. Yoon, S. Yoo, Y. Choi, . Ho, Y. Chung et al., Functional Phenotype of Synovial Monocytes Modulating Inflammatory T-Cell Responses in Rheumatoid Arthritis (RA), PLOS ONE, vol.9, issue.10, p.109775, 2014.

A. K. Rana, Y. Li, Q. Dang, F. 9. Yang, E. Gonzalo-gil et al., Role of Transforming Growth Factor-Beta (TGF) Beta in the Physiopathology of Rheumatoid Arthritis, Reumatología Clínica (English Edition). 1 mai, vol.10, issue.3, pp.174-183, 2014.

F. Rannou, M. François, M. Corvol, and F. Berenbaum, Cartilage breakdown in rheumatoid arthritis, Joint Bone Spine. janv, vol.73, issue.1, pp.29-36, 2006.

, Polyarthrite rhumatoïde, vol.121, p.30

, Update of French society for rheumatology recommendations for managing rheumatoid arthritis -ScienceDirect

D. Sur,

, Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis -Prevoo -1995 -Arthritis &amp

. Rheumatism--wiley, Online Library

D. Sur,

, Measurement of patient outcome in arthritis -Fries -1980 -Arthritis & Rheumatism -Wiley Online Library

D. Sur,

, Les médicaments de la douleur : les paliers de l'OMS -Fédération Hospitalière de France (FHF)

D. Sur, Caractéristiques pharmacologiques des principaux corticoïdes destinés à la voie orale

D. Sur,

B. Combe, R. Landewe, C. I. Daien, C. Hua, D. Aletaha et al., 2016 update of the EULAR recommendations for the management of early arthritis, Annals of the Rheumatic Diseases. juin, vol.76, issue.6, pp.948-59, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01794370

, Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts | Annals of the Rheumatic Diseases

D. Sur,

, Disease Activity Score, p.28

, Disponible sur

A. College and . Rheumatology, Preliminary definition of improvement in rheumatoid arthritis

D. Sur, 7779114?ordinalpos=13&itool=E in orthopaedic operations, including total joint replacements, in patients with rheumatoid arthritis between 2001 and 2007: data from review and metaanalysis: Anti-tumor necrosis factor ? therapy and cardiovascular events in rheumatoid arthritis -Barnabe -2011 -Arthritis Care &amp

. Research--wiley, Online Library

D. Sur,

, Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde -ScienceDirect

D. Sur,

. Who-|-about,

S. Sadiq, S. Kaur, V. Khajuria, S. Gupta, and A. Sharma, Complementary and alternative medicine use in medical OPD patients of rheumatoid arthritis in a tertiary care hospital, National Journal of Physiology, Pharmacy and Pharmacology, vol.6, issue.4, pp.305-314, 2016.

C. Report and . Pdf,

J. K. Rao, K. Kroenke, K. A. Mihaliak, S. C. Grambow, and M. Weinberger, Rheumatology patients' use of complementary therapies: results from a one-year longitudinal study, Arthritis Rheum, vol.49, issue.5, pp.619-644, 2003.

C. Chèze and . Cours-de-phytothérapie, Université de Bordeaux; 2015. 117. Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages

D. Sur,

, Musculoskelet Neuronal Interact. juin, vol.1, issue.4, pp.377-85, 2001.

R. O. Williams, Collagen-induced arthritis as a model for rheumatoid arthritis, Methods Mol Med, vol.98, pp.207-223, 2004.

M. Hayder, Doctorat d'Université en Immunologie -EDBSB -Toulouse, p.202

W. Van-eden, J. P. Wagenaar-hilbers, and M. H. Wauben, Adjuvant arthritis in the rat, Curr Protoc Immunol. mai, 2001.

, Adjuvant Induced Arthritis -Adjuvants

Z. Disponible-sur-;-szekanecz, M. M. Halloran, M. V. Volin, J. M. Woods, R. M. Strieter et al., Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis, Arthritis Rheum. juin, vol.43, issue.6, pp.1266-77, 2000.

, Thunder God Vine

. Nccih, , 2011.

D. Sur,

C. A-mechanistic-overview-of-triptolide, Natural Products from Tripterygium wilfordii Hook F. -PubMed -NCBI

D. Sur,

S. Chrubasik, M. H. Pittler, B. D. Roufogalis, and . Zingiberis,

W. Zhang and L. Lim, Effects of Spice Constituents on P-Gp-Mediated Transport and Cyp3a4-Mediated Metabolism in Vitro, Drug Metab Dispos, issue.2, 2008.

D. Sur,

B. Gupta, K. K. Ghosh, and R. C. Gupta, Chapter 39 -Thymoquinone, Gupta RC, éditeur. Nutraceuticals [Internet

, A study of the anti-inflammatory activity of Nigella sativa L. and thymoquinone in rats

D. Sur, The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa

S. Umar, O. Hedaya, A. K. Singh, and S. Ahmed, Thymoquinone inhibits TNF-?-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation, Toxicol Appl Pharmacol. 15 sept, vol.287, issue.3, pp.299-305, 2015.

, Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. -PubMed -NCBI

D. Sur,

, Immunosuppressive and cytotoxic properties of Nigella sativa

D. Sur,

, Effects of formaldehyde inhalation on humoral immunity and protective effect of Nigella sativa oil: An experimental study. -PubMed -NCBI

D. Sur,

, Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. -PubMed -NCBI

D. Sur,

, Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: a random

D. Sur,

W. Kooti, Z. Hasanzadeh-noohi, N. Sharafi-ahvazi, M. Asadi-samani, and D. Ashtary-larky, Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa), Chin J Nat Med, vol.14, issue.10, pp.732-777, 2016.

H. M. Korashy, F. I. Al-jenoobi, M. Raish, A. Ahad, A. M. Al-mohizea et al., Impact of Herbal Medicines like Nigella sativa, Trigonella foenum-graecum, and Ferula asafoetida, on Cytochrome P450 2C11 Gene Expression in Rat Liver, Drug Res (Stuttg). juill, vol.65, issue.7, pp.366-72, 2015.

D. Sur,

X. Chen, J. Lu, A. M. Ma, Z. Zong, H. Yang et al., Anti-inflammatory effect of resveratrol on adjuvant arthritis rats

M. Tsai, L. Hsu, C. Lee, Y. Chiang, M. Lee et al., Resveratrol inhibits urban particulate matter-induced COX-2/PGE2 release in human fibroblastlike synoviocytes via the inhibition of activation of NADPH oxidase/ROS/NF-?B, Int J Biochem Cell Biol, vol.88, pp.113-136, 2017.

C. Ma, Y. Wang, L. Dong, M. Li, and W. Cai, Anti-inflammatory effect of resveratrol through the suppression of NF-?B and JAK/STAT signaling pathways, Acta Biochim Biophys Sin (Shanghai). mars, vol.47, issue.3, pp.207-220, 2015.

G. Xuzhu, M. Komai-koma, B. P. Leung, H. S. Howe, C. Mcsharry et al., Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and Bcell function, Ann Rheum Dis. janv, vol.71, issue.1, pp.129-164, 2012.

L. Hao, Y. Wan, X. J. Tang, Q. Deng, H. Chen et al., A study of Sirt1 regulation and the effect of resveratrol on synoviocyte invasion and associated joint destruction in rheumatoid arthritis, Molecular Medicine Reports, vol.16, issue.4, pp.5099-106, 2017.

, Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study

D. Sur,

J. A. Crowell, P. J. Korytko, R. L. Morrissey, T. D. Booth, and B. S. Levine, Resveratrol-associated renal toxicity, Toxicol Sci. déc, vol.82, issue.2, pp.614-623, 2004.

L. D. Williams, G. A. Burdock, J. A. Edwards, M. Beck, and J. Bausch, Safety studies conducted on highpurity trans-resveratrol in experimental animals, Food Chem Toxicol. sept, vol.47, issue.9, pp.2170-82, 2009.

M. G. Novelle, D. Wahl, C. Dieguez, M. Bernier, and R. De-cabo, Resveratrol supplementation, where are we now and where should we go?, Ageing Res Rev. mai, vol.21, pp.1-15, 2015.

H. Chow, L. Garland, C. Hsu, D. R. Vining, W. M. Chew et al., Resveratrol Modulates Drug and Carcinogen Metabolizing Enzymes in a Healthy Volunteer Study, Cancer Prev Res (Phila). sept, vol.3, issue.9, pp.1168-75, 2010.

J. Bruneton and J. Bruneton, Pharmacognosie -Phytochimie, plantes médicinales, « "4e éd., revue et augmentée" ». Paris: Tec & Doc -Éditions médicales internationales, p.229, 2009.

D. Sur,

. Quercetin, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis, Journal of Medicinal Food

D. Sur,

, Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1

D. Sur,

, The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial

D. Sur,

, Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients

D. Sur, The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis

D. Sur,

O. Dangles, C. Dufour, C. Manach, C. Morand, and C. Remesy, Binding of flavonoids to plasma proteins, Meth Enzymol, vol.335, pp.319-352, 2001.

M. Poór, G. Boda, P. W. Needs, P. A. Kroon, B. Lemli et al., Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme, Biomed Pharmacother. avr, vol.88, pp.574-81, 2017.

M. Poór, Y. Li, S. Kunsági-máté, J. Petrik, S. Vladimir-kne?evi? et al., Molecular displacement of warfarin from human serum albumin by flavonoid aglycones, J Lumin, vol.142, pp.122-129, 2013.

. Qu'est-ce-qu'un-essai-clinique?--ansm, Agence nationale de sécurité du médicament et des produits de santé

D. Sur,

D. Sur,